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Psoriasis and the MAITing Game:
A Role for IL-17Aþ Invariant TCR
CD8þ T Cells in Psoriasis?
Andrew Johnston1 and Johann E. Gudjonsson1
Recent findings have indicated that the majority of IL-17AþCD8þ T cells in the
blood belong to a subset of innate T cells named mucosa-associated invariant
T cells (MAITs). In this issue, Teunissen and colleagues (2014) demonstrate that,
although MAIT cells are found in psoriatic skin, they are not increased in
abundance and that the majority of IL-17AþCD8þ T cells in plaques of psoriasis
are devoid of MAIT cell characteristics.
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Mucosa-associated invariant T cells
(MAITs) are a recently characterized
T-cell subset that together with gd T
cells and invariant natural killer T cells
join the ranks of unconventional T cells
(Figure 1). Similar to other subsets of
innate T cells (Laggner et al., 2011),
attempts have been made to implicate
these cells in the pathogenesis of psori-
asis (Bonish et al., 2000), especially
because IL-17 is now known to have a
prominent role in the pathogenesis of
psoriasis and because MAIT cells have
been shown to account for the majority
of IL-17A-producing CD8þ T cells in
the blood (Dusseaux et al., 2011). In
their article,Teunissen et al. (2014) show
that, although the number of IL-17A-
producing CD8þ T cells in the blood
correlates with psoriasis disease severity
and although MAIT cells are found in
psoriatic skin, they are not increased
in frequency compared with normal
skin; moreover, a large proportion of
the IL-17A-producing CD8þ T cells
in skin plaques are conventional
CD8þ T cells.
MAIT cells are evolutionarily con-
served, and they express an invariant
TCR a-chain (Va7.2 and Ja33) that is
restricted by the nonclassical major
histocompatibility complex (MHC)
class I molecule MHC–related protein 1
(MR1; reviewed in Le Bourhis et al.,
2011). In contrast to conventional
T cells that have a lag in terms of gene-
rating effector cells and mounting
immune responses, these innate T-cell
subtypes express an effector-memory
phenotype upon maturation, and they
have a capacity for rapid effector
function (Le Bourhis et al., 2011). One
of the striking differences between MAIT
cells and conventional CD8þ T cells is
that MAIT cells are uniquely activated
by vitamin B2 (riboflavin) metabolites
that are presented in the context of the
MR1 protein on antigen-presenting cells
(APCs) and on epithelial cells. Mammals
do not synthesize vitamin B2, relying
on certain bacteria and yeasts for this.
Interestingly, only microbes with func-
tional biosynthetic pathways for vitamin
B2 have been shown to activate MAIT
cells (e.g., Escherichia coli, Staphylo-
coccus aureus, and Mycobacterium
tuberculosis but not Streptococcus or
Listeria), which may also explain the
lack of response by MAIT cells to virus-
infected cells. Thus, MAIT cells might
provide a means to control certain
commensals and/or to offer a novel
mechanism to detect the overgrowth or
cellular infection by certain pathogens.
This might occur by detecting the pre-
sence of their biosynthetic intermediates,
which would be akin to gd T cells’
recognition of intermediates of the
alternative pathway of cholesterol syn-
thesis used by some bacteria and eukar-
yotic pathogens but not by mammalian
cells. No studies have been reported to
address the role of MR1 in psoriasis, but
its mRNA expression in lesional psoriatic
skin is decreased by approximately 30%
compared with normal healthy skin
(unpublished observation).
In contrast to mice, in which this
subset is relatively rare, MAIT cells
constitute a significant proportion of
T cells in humans, accounting for bet-
ween 1 and 10% of T cells in peripheral
blood, as well as representing a signi-
ficant population of T cells in the human
liver, gut mucosa, and mesenteric,
but not peripheral, lymph nodes. MAIT
cells are defined as CD3þCD4– cells
expressing TCR Va7.2, with high levels
of NK receptor CD161 (previously asso-
ciated with all IL-17-producing T cells),
together with the IL-18 receptor (IL-
18Ra) and the Th17-associated trans-
cription factor RORgt (reviewed in Le
Bourhis et al. (2011)). MAIT cells also
express high levels of the chemokine
receptors CCR6 and CXCR6, with
intermediate expression of CCR9; such
chemokine receptor expression likely
explains the abundance of these cells
in the periphery, particularly the gut
and liver. The multidrug efflux trans-
porter protein ABCB1 is also expressed
strongly by MAIT cells. ABCB1 is
typically expressed by long-lived non-
cycling (G0) cells, which together with
their expression of CD45RO and CD95
suggests that these cells are long-lived
effector T cells.
MAIT cell activation occurs when
APCs, epithelial cells, or fibroblasts pre-
sent a vitamin B2 metabolite (typically
containing a ribityl carbohydrate group)
in the grove of the MR1 molecule to
the responding MAIT cell. The precise
pathway for such antigen presentation
is poorly defined, but it is independent
of TAP and invariant chains (i.e., the
typical class I and class II presentation
pathways), and it is independent of
Toll-like receptor signaling, because
MyD88, TRIF, and NLRP3 knockdown
had no effect on MAIT cell activation
by APCs. Isolated human MAIT cells
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secrete IFN-g, TNF-a (tumor necrosis
factor-a), CCL20, and granzyme B
rapidly after stimulation with CD3/
CD28 antibodies or bacterially infected
APCs, although phorbol 12-myristate
13-acetate-ionomycin stimulation is
required for the reported large amounts
of IL-17 to be secreted. This may reflect
the intensity of in vitro stimulation
required to elicit IL-17 production from
both CD8þ T cells and MAIT cells, or it
might suggest that MAIT cells require
more co-stimulation from a cytokine or
cell surface ligand expressed by the
APCs, e.g., NKG2D or CD161 ligation,
to drive the MAIT cell response fully.
Lesional psoriasis skin is highly
enriched with IL-17þCD8þ T cells
(Ortega et al., 2009; Res et al., 2010).
A recent report by Dusseaux et al.
(2011) indicated that the majority of
IL-17A-producing CD8þ T cells in the
blood are MAIT cells; thus, the true
identity of the IL-17þCD8þ T cells
in the skin has been questioned. CD8þ
T cells have long been implicated
as critical players in the pathogenesis
of psoriasis. In contrast to CD4þ T cells
that are predominantly found in the
upper dermis of psoriatic skin lesions,
CD8þ T cells are the predominant
T cells in the epidermis (Baker et al.,
1984). There is a strong correlation bet-
ween the presence of epidermal T cells
and the development of epidermal
hyperplasia, a key feature of psoriasis,
and studies blocking the entry of T cells
into the epidermis, through blocking of
the a1b1 integrin, prevent development
of psoriasis in a xenograft mouse model
of psoriasis (Conrad et al., 2007). Con-
ventional CD8þ T cells detect and
respond to peptide antigens presented
on MHC class I molecules, such as
HLA-Cw6, which is the most promi-
nent risk gene for the development of
psoriasis (Nair et al., 2006). Consistent
with the potential role of conventional
CD8þ T cells in the pathogenesis of
psoriasis is the finding that the CD8þ T
cells in the psoriatic epidermis show
oligoclonal expansion with preferential
expansion of particular Vb families
(reviewed in Valdimarsson et al. (2009)).
About 50–60% of epidermal T cells
secrete IL-17A (Kryczek et al., 2008).
IL-17A has been shown to be a critical
cytokine in the pathogenesis of psori-
asis. This has been determined through
genetic studies, with the identification
of genetic risk variants within, or close
to, several genes involved in IL-17A res-
ponses and by the therapeutic responses
seen in psoriasis when treated with
drugs that target IL-17A. IL-17A has
wide-ranging pro-inflammatory effects.
It induces secretion of cytokines such
as IL-6, IL-8, CCL20, and GM-CSF by
keratinocytes and fibroblasts, resulting
in the recruitment of T cells, macro-
phages, and neutrophils to skin. Further-
more, IL-17A synergizes with other pro-
inflammatory cytokines such as IFN-g
(Kryczek et al., 2008), and its effects are
amplified by TNF-a. The cellular source
of IL-17A in psoriatic skin has not been
identified with certainty. Immunohisto-
chemistry demonstrates that the major
portion of staining for IL-17A in psoriatic
skin is associated with mast cells and
neutrophils, with a minor portion being
from T cells (Lin et al., 2011). However,
as T cells express and secrete IL-17A
rapidly, the main source of IL-17A in
skin appears to be lesional CD4þ and
CD8þ T cells (Res et al., 2010). Interes-
tingly, when compared with healthy
normal skin, the frequency of CD4þ
IL-17Aþ T cells (Th17) is unchanged,
whereas CD8þ IL-17þ T cells (Tc17)
are highly enriched (Res et al., 2010).
This does not necessarily mean that
Th17 cells do not contribute to IL-17
production in psoriatic skin, as these
cells are activated in psoriatic lesions
but are resting in normal healthy skin. In
Clinical Implications
 IL-17-secreting CD8þ T cells in the epidermis may have a major role in
driving the psoriasis disease process.
 The majority of lesional psoriatic IL-17A-producing CD8þ T cells are
conventional T cells, which are driven by antigen-specific responses.
 Targeting or blocking the function of IL-17AþCD8þ T cells in the psoriatic
epidermis is an attractive avenue for future therapeutics.
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Figure 1. Mucosa-associated invariant T cells (MAITs) join the ranks of unconventional T cells.
Characterized by their limited TCR rearrangements, unconventional T cells respond more quickly
compared with their conventional counterparts, stationed in peripheral tissues and poised to act. These
cells expand the repertoire of antigens recognized by T cells, with the invariant natural killer (iNK) T cells
responding to lipid antigens presented by CD1d, and several clones of gd T cells recognizing a diverse
array of structures including phospho-antigens and sphingolipids apparently independent of major
histocompatibility complex (MHC)-antigen presentation. Like conventional ab T cells, MAIT cells
recognize antigens presented in the context of an MHC-like molecule, MR1, on the surface of antigen-
presenting cells (green) or epithelia (brown). Thus far, antigens derived from the structures of vitamins B2
and B9 containing a ribityl carbohydrate group have been identified to activate MAIT cells. MAIT cells
express many of the markers associated with Th17 cells (RORC, CD161, and CCR6) and account for
the majority of IL-17-producing CD8þ T cells in the blood but only a fraction of epidermal
IL-17þCD8þ cells.
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addition, Tc17 cells do not produce IL-
17 exclusively, as most CD8þ IL-17þ
cells also secrete TNF-a and about half
produce IFN-g along with IL-17 (Ortega
et al., 2009), a feature that can also be
attributed to MAIT cells.
In the light of the information pre-
sented here, it is important to determine
whether the IL-17þCD8þ T cells in
psoriatic skin are conventional MHC
class I–restricted T cells or belong to
the MAIT subset. In this paper Teunissen
et al. (2014) demonstrate that, although
MAIT cells are found in psoriatic
skin, they represent only a proportion of
IL-17A-expressing CD8þ T cells
and that the majority of Tc17 clones
derived from psoriatic epidermis are
conventional T cells. In addition, the
investigators demonstrate that the
frequency of Tc17 cells in peripheral
blood correlates with disease severity,
although they did not take the next step
of determining whether the cells belong
to the MAIT subset rather than being
conventional CD8þ T cells. Taken
together, these data suggest that MAIT
cells are unlikely to have a major role
in the pathogenesis of psoriasis and,
instead, focus the spotlight back on
conventional Tc17 cells as the critical
CD8þ T-cell population in psoriasis
pathogenesis. This, along with other
evidence supporting the role of CD8þ
T cells in psoriasis (Elder et al., 2010),
indicates that these cells may have been
either selectively recruited to or expan-
ded in the epidermis of psoriatic skin.
Expansion might occur after recogni-
tion of antigens in the context of MHC
class I, with HLA-Cw*0602 being most
likely the restriction element in a large
proportion of patients with psoriasis
(Nair et al., 2006). This is a relatively
unexplored avenue of research in
psoriasis, but addressing the nature of
the antigen specificity of conventional
CD8þ T cells in psoriasis is very attrac-
tive. It holds considerable promise
because it is the most likely approach
to eventually ‘‘cure’’ psoriasis.
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Manipulated Microenvironment in
Human Papilloma Virus–Infected
Epithelial Cells: Is the CD40–CD154
Pathway Beneficial for Host or Virus?
Takatoshi Shimauchi1 and Vincent Piguet1
In this issue, Tummers et al. (2014) demonstrate that high-risk human papilloma
viruses (hrHPVs) attenuate the magnitude of responses to CD40 ligation and the
epithelial cells’ (ECs) capacity to attract leukocytes. These results suggest that
hrHPVs can escape from host immune surveillance by modulating pro-inflamma-
tory responses in infected ECs, resulting in persistent infections and potential
carcinogenesis.
Journal of Investigative Dermatology (2014) 134, 2866–2868; doi:10.1038/jid.2014.357
The human papilloma virus (HPV) is
a non-enveloped double-stranded DNA
virus that infects human epithelial
tissues, including skin, anogenital epi-
thelia, and oral cavity mucosa. In parti-
cular, hrHPVs, including HPV16 and
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